A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. [electronic resource]
Producer: 19960305Description: 330-9 p. digitalISSN:- 0022-1899
- AIDS Vaccines -- administration & dosage
- Adult
- Amino Acid Sequence
- Dose-Response Relationship, Immunologic
- Double-Blind Method
- Enzyme-Linked Immunosorbent Assay
- Female
- HIV Antibodies -- analysis
- HIV Envelope Protein gp120 -- chemistry
- HIV-1 -- immunology
- Humans
- Lymphocyte Activation
- Male
- Middle Aged
- Molecular Sequence Data
- Neutralization Tests
- Peptide Fragments -- chemistry
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.